KFDA Views Hanmi's Anti-obesity Drug Slimer as Generic Version

The Korea Food and Drug Administration (KFDA) recently expressed of its position to recognize Hanmi Pharmaceutical's anti-obesity drug Slimer as an equivalent generic version to the original drug Reductil by Abbott Korea, thus treating both as the same products.

According to the industry source, the above is based on the KFDA's assessment that both Slimer (sibutramine mesylate) and Reductil ...